Clinical Trial

Cardiovascular Effects of E-Cigarettes

Study Description

Short-Term Cardiovascular Effects of E-Cigarettes: Influence of Device Power

This study will examine the short-term cardiovascular (CV) effects of e-cigarette device power in a randomized, crossover clinical and behavioral pharmacology study of experienced adult e-cigarette users (N=21). The specific aim is to determine the impact of e-cigarette power on nicotine pharmacology, systemic exposure to toxic volatile organic compounds (VOCs), and short-term cardiovascular effects.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Electronic Cigarette

E-cigarette Device: The delivery device will be a variable wattage all-in-one device with operating wattage of 7.0 - 75.0 W, which is inclusive of the three power levels we intend to study.

Additional Information

Official Study Title

Short-Term Cardiovascular Effects of E-Cigarettes: Influence of Device Power

Clinical Trial ID

NCT03839745

ParticipAid ID

dJ6X9d